-+ 0.00%
-+ 0.00%
-+ 0.00%

*Kalaris Therapeutics: Planned Phase 3 Clinical Trials Remain on Track for 2027 Yr-end Initiation

Dow Jones·05/12/2026 12:02:00

Please log in to view news